These findings suggest that SPOP may have an oncogenic role in RCC, potentially due to its accumulation in the cytoplasm, which impairs its ability to promote the ubiquitination and degradation of substrates typically regulated in the nucleus. This evidence concerns the gene SPOP and renal cell carcinoma.